Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease.
Villa C, Ridolfi E, Fenoglio C, Ghezzi L, Vimercati R, Clerici F, Marcone A, Gallone S, Serpente M, Cantoni C, Bonsi R, Cioffi S, Cappa S, Franceschi M, Rainero I, Mariani C, Scarpini E, Galimberti D. Villa C, et al. Among authors: vimercati r. J Alzheimers Dis. 2013;35(3):487-94. doi: 10.3233/JAD-122263. J Alzheimers Dis. 2013. PMID: 23435408
Caregiver Tele-Assistance for Reduction of Emotional Distress During the COVID-19 Pandemic. Psychological Support to Caregivers of People with Dementia: The Italian Experience.
Rotondo E, Galimberti D, Mercurio M, Giardinieri G, Forti S, Vimercati R, Borracci V, Fumagalli GG, Pietroboni AM, Carandini T, Nobili A, Scarpini E, Arighi A. Rotondo E, et al. Among authors: vimercati r. J Alzheimers Dis. 2022;85(3):1045-1052. doi: 10.3233/JAD-215185. J Alzheimers Dis. 2022. PMID: 34806608 Clinical Trial.
Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study.
Lugaresi A, Florio C, Brescia-Morra V, Cottone S, Bellantonio P, Clerico M, Centonze D, Uccelli A, di Ioia M, De Luca G, Marcellusi A, Paolillo A; BRIDGE study group. Lugaresi A, et al. BMC Neurol. 2012 Mar 5;12:7. doi: 10.1186/1471-2377-12-7. BMC Neurol. 2012. PMID: 22390218 Free PMC article. Clinical Trial.
Does botulinum toxin affect psycho-social aspects in dystonia?
Marfoli A, Mameli F, Aiello EN, Ruggiero F, Sandi A, Mellace D, Curti B, Vimercati R, Poletti B, Ticozzi N, Chieffo D, Santangelo G, Barbieri S, Priori A, Ferrucci R. Marfoli A, et al. Among authors: vimercati r. J Neural Transm (Vienna). 2024 Jun 4. doi: 10.1007/s00702-024-02785-z. Online ahead of print. J Neural Transm (Vienna). 2024. PMID: 38832965
Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG.
Olivieri A, Santini G, Patti C, Chisesi T, De Souza C, Rubagotti A, Aversa S, Billio A, Porcellini A, Candela M, Centurioni R, Congiu AM, Brunori M, Nati S, Spriano M, Vimercati R, Marino G, Contu A, Tedeschi L, Majolino I, Crugnola M, Sertoli MR; NHLCSG. Olivieri A, et al. Among authors: vimercati r. Ann Oncol. 2005 Dec;16(12):1941-8. doi: 10.1093/annonc/mdi399. Epub 2005 Sep 12. Ann Oncol. 2005. PMID: 16157621 Free article. Clinical Trial.
Fludarabine, cyclophosphamide and mitoxantrone for untreated follicular lymphoma: a report from the non-Hodgkin's lymphoma co-operative study group.
Santini G, Chisesi T, Nati S, Porcellini A, Zoli V, Rizzoli V, Zupo S, Marino G, Rubagotti A, Polacco A, Spriano M, Vimercati R, Congiu AM, Ravetti JL, Aversa S, Candela M, Patti C. Santini G, et al. Among authors: vimercati r. Leuk Lymphoma. 2004 Jun;45(6):1141-7. doi: 10.1080/10428190310001623874. Leuk Lymphoma. 2004. PMID: 15359993
37 results